2 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Terminated 1 |
Follow YH12852: new trials by email Literature Review of YH12852 trials Research Report on YH12852
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of the Absorption, Metabolism, and Excretion and the Absolute Bioavailability of YH12852 YH12852, 14C-labeled YH12852 - Constipation | Phase 1 | Completed | Seoul National University Hospital | 10 | 2017-03-16 | 2017-12-22 |
| A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia YH12852 0.1 mg, YH12852 0.25 mg, YH12852 0.5 mg - Functional Dyspepsia | Phase 2 | Terminated | Yuhan Corporation | 12 | 2015-10-01 | 2022-01-13 |
| Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of YH12852 After Oral Administration in Healthy Male Subjects YH12852, Prucalopride, Placebo - Healthy | Phase 1 | Completed | Yuhan Corporation | 127 | 2013-08-01 | 2015-05-08 |
Constipation (1)
Yuhan Corporation (2) · Seoul National University Hospital (1)
South Korea (3)
Howard Lee, MD., PhD (1) · Poong Lyul Lee, MD, Ph.D (1)